Results 111 to 120 of about 13,638 (219)
Biological Ablation of Sentinel Lymph Node Metastasis in Submucosally Invaded Early Gastrointestinal Cancer [PDF]
, 2014 Currently, early gastrointestinal cancers are treated endoscopically, as long as there are no lymph node metastases. However, once a gastrointestinal cancer invades the submucosal layer, the lymph node metastatic rate rises to higher than 10%. Therefore,
Fujiwara, Toshiyoshi +11 more
core +1 more source
Editorial: Oncolytic virotherapy
Frontiers in Molecular Biosciences, 2023 Ahmed Majeed Al-Shammari +2 more
openaire +3 more sources
Stem Cells International, 2017 Antitumor efficacy of systemically administered oncolytic adenoviruses (OAdv) is limited due to diverse factors such as liver sequestration, neutralizing interactions in blood, elimination by the immune system, and physical barriers in tumors.
R. Moreno +6 more
doaj +1 more source
, 2020 Cancer is a disease that humans have been struggling to combat for centuries. It originates from the accumulation of several mutations over the life of a cell that causes it to evade cell death and multiply rapidly.
Current, Joseph R
core +1 more source
Immunotherapeutic potential of oncolytic vaccinia virus [PDF]
, 2014 The concept of oncolytic viral therapy was based on the hypothesis that engineering tumor-selectivity into the replication potential of viruses would permit direct destruction of tumor cells as a result of viral-mediated lysis, resulting in amplification
Thorne, SH
core +1 more source
Cytolytic Effects of Newcastle Disease Virus Strain Af2240 on Dbtrg.05mg and U-87mg Brain Tumor Cell Lines [PDF]
, 2008 Newcastle disease virus (NDV) is a potential oncolytic agent as it can replicate up to 10,000 times better in human cancer cells than in most normal human cells. Several strains of NDV were reported to induce cytolysis to various cancerous cell lines.
Saeed, Rola Ali
core
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery
Frontiers in ImmunologyOnco-virotherapy is an emergent treatment for cancer based on viral vectors. The therapeutic activity is based on two different mechanisms including tumor-specific oncolysis and immunostimulatory properties.
Hélène Lê +11 more
doaj +1 more source
Engineered bovine herpesvirus type 4: a new tool against glioma stem-like cells? [PDF]
, 2015 Glioblastoma (GBM) is a grade IV primary brain tumor (WHO 2007). Despite last progresses in surgery, chemo- and radiotherapy, this brain tumor is still incurable and it always recurs (Stupp et al, 2009).
Moschioni, Chiara
core
Syöpää sairastavien potilaiden elämänlaatu virushoitokokeilun aikana [PDF]
, 2013 Opinnäytetyön tarkoituksena on kuvata syöpää sairastavien potilaiden kokemaa elämänlaatua ja sen muuttumista virushoitokokeilun aikana. Opinnäytetyön tavoitteena on pohtia virushoidon merkitystä potilaiden kokemaan elämänlaatuun ja tuottaa tietoa ...
Helander, Marjukka, Vesala, Tuulikki
core
Molecular Therapy: OncologyThis study reports a strategy to overcome immune escape of tumors during viro-immunotherapy due to tumor heterogeneity. We pursued a dual-targeting approach of epidermal growth factor receptor (EGFR) and cellular mesenchymal epithelial transition factor (
Martin A. Boos +8 more
doaj +1 more source